Results 101 to 110 of about 180,078 (140)

The Presence of Risk and Protective HLA-DQ Haplotype Combinations and PLA2R1 Risk SNP in Hungarian Patients with Membranous Nephropathy. [PDF]

Int J Mol Sci
Bajcsi D, Maróti Z, Endreffy E, Légrády P, Ábrahám G, Iványi B.   +5 more
europepmc   +1 more source

Organization, sequence and expression of the HLA-B27 gene [PDF]

, 1985
Doerner, C., Kuon, W., Lang, M., Riethmüller, Gert, Weiss, Elisabeth H.   +4 more
core   +1 more source

Two-pore channels in MR1-dependent presentation of Mycobacterium tuberculosis infection. [PDF]

PLoS Pathog
Karamooz E, Kim SJ, Peterson JC, Tammen AE, Soma S, Soll ACR, Meermeier EW, Khuzwayo S, Lewinsohn DM.   +8 more
europepmc   +1 more source

Novel BCR-Targeting Fusion Proteins for Antigen-Specific Depletion of Alloreactive B Cells in Antibody-Mediated Rejection. [PDF]

Cells
Zhang J, Wei L, Song L, Lu X, Tan L, Li X, Fu L, Luo Q, Xie X, Zou Y.   +9 more
europepmc   +1 more source

Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy. [PDF]

Explor Target Antitumor Ther
Anilkumar AS, Thomas SM, Veerabathiran R.   +2 more
europepmc   +1 more source

Large-scale statistical mapping of T-cell receptor <i>β</i> sequences to human leukocyte antigens. [PDF]

Front Immunol
Zahid HJ, Taniguchi R, Ebert P, Chow IT, Gooley C, Lv J, Pisani L, Rusnak M, Elyanow R, Takamatsu H, Zhou W, Greissl J, Robins H, Carlson JM.   +13 more
europepmc   +1 more source

THLANet: A deep learning framework for predicting TCR-pHLA binding in immunotherapy applications. [PDF]

PLoS Comput Biol
Long X, Yang Q, Dong W, Li X, Wang K, Dong S, Luo G, Zhang X, Yang T, Gao X, Wang G.   +10 more
europepmc   +1 more source

Unequal Racial Access to Kidney Transplantation [PDF]

, 1993
Gaston Dooley, Laura
core   +2 more sources

Two homologous sequences of Grp78 and HSP70 represent tumor antigens shared with streptococcal superantigens in eliciting an antitumor immune response: an immunoinformatic investigation. [PDF]

Front Immunol
Finotti P.
europepmc   +1 more source

MetE: a promising protective antigen for tuberculosis vaccine development. [PDF]

Front Immunol
Almujri SS, Stylianou E, Nicastri A, Satti I, Korompis M, Li S, De Voss CJ, Polo Peralta Alvarez M, Tanner R, Bettencourt PJG, Ternette N, McShane H.   +11 more
europepmc   +1 more source